Welcome to the ATX West Presentation Store. Here you can view and download conference and/or show floor theater presentations before, during, and after the event. If you’re looking for a presentation from a specific session that you’re unable to find here, note that it’s likely because the presenter has not provided permission for external use or has not yet shared their presentation with us. Please check back after the event for a more complete catalogue of available presentations.
John Crombie is Founder and President of UpStart Product Development, a company specializing in creating and nurturing high potential entrepreneurial opportunities and preparing them for early seed funding. He is CEO for one of these startups, Centaur Sports Medicine. This is a company dedicated to commercializing a portfolio of highly disruptive performance optimization products. John is currently conducting clinical evaluations of these products with a major hospital network and several professional sports teams. John has developed innovative and successful product portfolios for other diverse markets beyond sports medicine, including orthopedics and spine, plastic and reconstructive surgery, general surgery, women’s health procedures, diagnostic medical software, consumer, recreational, and global emerging markets, specifically China. He has achieved a solid track record of commercializing innovations and intellectual property while identifying and growing new opportunities. He combines strong technical ability with leadership and creativity to drive strategic and tactical initiatives. John was previously employed by numerous industry leading organizations, such as several Johnson & Johnson companies, several Pfizer companies, Stryker, Allergan, and numerous private organizations and startups. He holds dual BS degrees in Physiology and Mechanical Engineering and an MS in Business Management. Most notably, John has commercialized 70% of his 37 patents into new products spanning across six companies, resulting in more than $2B in sales.